When the buprenorphine dose is inadequate plus the CYP3A4 inducer cannot be lessened or discontinued, transition the client back to your buprenorphine formulation that permits dose adjustments. pentobarbital will decrease the level or influence of tamoxifen by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Possible